M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

Phase 2

Completed

Conditions: Amenorrhea
Premature Ovarian Failure
Ovarian Function Insufficiency

Interventions: Drug: Leuprolide Acetate
Behavioral: Questionnaire
Procedure: Hematopoietic Stem Cell Transplantation

First Posted Date: 2007-01-31

Last Posted Date: 2013-07-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 60

Registration Number: NCT00429494

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Herceptin and GM-CSF for Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Herceptin
Drug: GM-CSF

First Posted Date: 2007-01-31

Last Posted Date: 2012-12-06

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 18

Registration Number: NCT00429104

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Fludarabine
Drug: Melphalan
Procedure: Stem Cell Infusion

First Posted Date: 2007-01-31

Last Posted Date: 2012-08-07

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 19

Registration Number: NCT00429572

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Survey of the Need for Information on Fertility and Menopause-Related Treatment Effects Among HSCT Patients

Completed

Conditions: Stem Cell Transplantation

Interventions: Behavioral: Survey

First Posted Date: 2007-01-31

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 196

Registration Number: NCT00429455

Locations: 🇺🇸
U.T. M.D. Anderson Cancer Center, Houston, Texas, United States

3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate

Not Applicable

Terminated

Conditions: Prostate Cancer

Interventions: Procedure: AIR-MRSI
Procedure: PFC-MRSI

First Posted Date: 2007-01-31

Last Posted Date: 2015-01-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 8

Registration Number: NCT00429338

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer

Phase 3

Terminated

Conditions: Breast Cancer

Interventions: Drug: Goserelin

First Posted Date: 2007-01-31

Last Posted Date: 2016-05-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1

Registration Number: NCT00429403

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
🇯🇵
St. Luke's International Hospital, Tokyo, Japan

Interest in Spirituality and Oncology: Is It An International Phenomenon?

Withdrawn

Conditions: Stress

Interventions: Behavioral: Survey

First Posted Date: 2007-01-31

Last Posted Date: 2011-11-18

Lead Sponsor: M.D. Anderson Cancer Center

Registration Number: NCT00429117

Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Phase 2

Terminated

Conditions: Renal Cell Cancer

Interventions: Drug: Fludarabine
Drug: Cyclophosphamide
Drug: Melphalan
Procedure: Stem Cell Transplant

First Posted Date: 2007-01-31

Last Posted Date: 2013-03-04

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 40

Registration Number: NCT00429026

Locations: 🇺🇸
U.T. M.D. Anderson Cancer Center, Houston, Texas, United States

Bevacizumab and Bortezomib in Patients With Advanced Malignancy

Phase 1

Completed

Conditions: Advanced Malignancy
Myeloma
Solid Tumors
Lymphoma

Interventions: Drug: Bevacizumab
Drug: Bortezomib

First Posted Date: 2007-01-30

Last Posted Date: 2013-02-12

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 104

Registration Number: NCT00428545

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Using Focus Groups to Assess the Impact of Environmental Health Science Programs for K-12 Educational Community

Completed

Conditions: Healthy

Interventions: Behavioral: Focus Group Discussion

First Posted Date: 2007-01-30

Last Posted Date: 2012-02-28

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 6

Registration Number: NCT00428402

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy